Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk

NCT: NCT05619003 · COMPLETED

NCT IDNCT05619003
StatusCOMPLETED
Start Date2022-08-15
Completion2022-12-08
SponsorColoplast A/S (INDUSTRY)
First posted
Last updated

Brief Summary

A post market clinical follow-up study investigating the safety of Biatain Silicone Sacral while used as prevention in hospital admitted patients at risk of developing a pressure injury.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑